Evidence map›Paper›PMID 40169828›Full record

ArticleScientific reports2025

Essential health risk communication for recovery after lifting evacuation orders following the Fukushima Daiichi nuclear power plant accident.

Makiko Orita, Kazutaka Tanaka, Isamu Amir, Hitomi Matsunaga, Yuya Kashiwazaki, Xu Xiao, Naofumi Akata, Tomisato Miura, Ikuo Kashiwakura, Naomi Ito and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Makiko OritaDepartment of Global Health, Medicine and Welfare, Atomic Bomb Disease Institute, Nagasaki University, Sakamoto, Nagasaki-city, Nagasaki, Japan.
Kazutaka TanakaInstitute of Radiation Emergency Medicine, Hirosaki University, Hon-cho, Hirosaki-city, Aomori, Japan.
Isamu AmirRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, Hikarigaoka, Fukushima City, Fukushima, Japan.
Hitomi MatsunagaDepartment of Global Health, Medicine and Welfare, Atomic Bomb Disease Institute, Nagasaki University, Sakamoto, Nagasaki-city, Nagasaki, Japan.
Yuya KashiwazakiDepartment of Global Health, Medicine and Welfare, Atomic Bomb Disease Institute, Nagasaki University, Sakamoto, Nagasaki-city, Nagasaki, Japan.
Xu XiaoDepartment of Global Health, Medicine and Welfare, Atomic Bomb Disease Institute, Nagasaki University, Sakamoto, Nagasaki-city, Nagasaki, Japan.
Naofumi AkataInstitute of Radiation Emergency Medicine, Hirosaki University, Hon-cho, Hirosaki-city, Aomori, Japan.
Tomisato MiuraInstitute of Radiation Emergency Medicine, Hirosaki University, Hon-cho, Hirosaki-city, Aomori, Japan.
Ikuo KashiwakuraHirosaki University Graduate School of Health Sciences, Hon-cho, Hirosaki-city, Aomori, Japan.
Naomi ItoRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, Hikarigaoka, Fukushima City, Fukushima, Japan.
Toshiki AbeRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, Hikarigaoka, Fukushima City, Fukushima, Japan.
Tomoaki TamakiDepartment of Health Risk Communication, Fukushima Medical University School of Medicine, Hikarigaoka, Fukushima City, Fukushima, Japan.
Noboru TakamuraDepartment of Global Health, Medicine and Welfare, Atomic Bomb Disease Institute, Nagasaki University, Sakamoto, Nagasaki-city, Nagasaki, Japan. takamura@nagasaki-u.ac.jp.
Shinji TokonamiInstitute of Radiation Emergency Medicine, Hirosaki University, Hon-cho, Hirosaki-city, Aomori, Japan. tokonami@hirosaki-u.ac.jp.
Masaharu TsubokuraRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, Hikarigaoka, Fukushima City, Fukushima, Japan. tsubo-m@fmu.ac.jp.

Funding

Ministry of Environment, Japan N/A
6 · The paper itself

Abstract

The Fukushima Daiichi Nuclear Power Plant, managed by the Tokyo Electric Power Company experienced a catastrophic accident in 2011 that led to widespread public anxiety regarding radiation exposure and the long-term impacts of evacuation. The recovery process has considerably varied across the affected municipalities, highlighting the need for effective and targeted risk communication to support residents in understanding these situations and making informed decisions. This study aims to examine the health risk communication strategies implemented by health and medical welfare experts in response to the lifting of evacuation orders in formerly evacuated areas. We provide an overview of the practical activities carried out by these experts, with a particular focus on the contributions of Fukushima Medical University, Hirosaki University, and Nagasaki University. Over the years, these institutions have played a key role in radiation protection and public health initiatives, guided by scientific and technical perspectives. Our findings underscore the necessity of evolving two-way communication practices that are responsive to specific needs of the recovery phase. Additionally, this study highlights the importance of integrating comprehensive health promotion activities with radiation health risk communication to ensure sustained attention to both physical and mental health. Furthermore, expert communication efforts remain essential in supporting social care professionals who are involved in the ongoing care of residents. Finally, the global sharing of Fukushima's recovery strategies is essential for providing insights that can inform future disaster preparedness efforts.

Indexed as

Disaster PlanningFukushima Nuclear AccidentHealth CommunicationCommunicationHumansJapanNuclear Power PlantsRadiation ExposureRadiation ProtectionDisastersRecoveryRisk communication

Identifiers

PMID40169828
PMCPMC11962077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.